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Summary 
Researchers are testing different treatments to induce modifi cations in both chemical composi­
tion and topography of implant surface, with the aim to ameliorate bone­to­implant contacts 
and hence improve osseointegration processes and biomechanical properties in the short and 
long term. Aim of the present research was the evaluation of MG63 osteoblast­like cells behav­
iour on polymeric coatings, electrosynthesized on titanium substrates, differently modifi ed in 
order to improve implant performances both in terms of osseointegration and infection preven­
tion. Cell viability data and scanning electron microscopy morphological observations were 
consistent with a good compatibility of modifi ed electrosynthesized coatings and suggest the 
use of this procedure to produce new bioactive titanium coatings for implant surgery.
Introduction 
The performances of implanted materials rely on the nature of the interactions 
between biomaterials and cells (Boyan et al, 1996; Puleo et al, 1999). Different treat­
ments have been performed to induce modifi cations in both chemical composition 
and topography of implant surface (Larsson at al, 1996) with the aim to ameliorate 
bone­to­implant contacts (Bigerelle et al, 2002), thus improving the osseointegration 
processes (Anselme et al, 2000).
Among the possible metal­implant surface modifi cation methods, the electro­
chemical polymerization (ECP) represents a valuable strategy to develop polymeric 
coatings able to improve implant biocompatibility. The ECP provides the advantage 
of obtaining polymeric coatings directly onto metal substrates having different shape 
and size with a one­step procedure (Kwok­Keung et al, 1995; Cram et al, 2002; De 
Giglio et al , 2010). 
Considering the polymers exploitable as biomedical devices, there are those 
obtained from acrylic monomers and, among these, hydrogels. The latter are poly­
meric three­dimensional networks able to retain a large amount of water and several 
studies were addressed to the development of various hydrogel networks for applica­
tions in drug release, tissue engineering, etc. (Montheard et al, 1992; Park et al, 1993; 
Ratner, 1993; Burdick et al, 2002). 
The development of thin hydrogel coatings by ECP on metal device surfaces is 
therefore an interesting target in order to obtain metal biomaterials releasing biologi­
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cally active molecules (antibiotics, growth factors, drugs, etc.) entrapped within the 
hydrogel layer during or post ECP. In this respect we have evaluated MG63 osteob­
last­like cells behaviour on Poly­Hydroxy Ethyl MethAcrylate (pHEMA) coatings, 
electrosynthesized on titanium substrates, differently modified in order to ameliorate 
implant performances. In one case this change was addressed to enhance both min­
eralization and angiogenesis at the implant site: for this purpose HEMA was copoly­
merised with a phosphate­containing monomer, 2­Methacryloyl­Oxy­Ethyl­Phosphate 
(MOEP) and subsequently loaded with recombinant human Vascular Endothelial 
Growth Factor (rhVEGF). Moreover, since infection in implant surgery is a serious 
complication and a major cause of implant failure, ciprofloxacin (CIP)­modified pHE­
MA coatings have also been developed.
Adhesion and viability of MG63 osteoblast­like cells on the modified pHEMA 
coatings as well as the capability of both systems to entrap and release the growth 
factor (rhVEGF) or the antibiotic (CIP) respectively have been assessed.
Materials and Methods
Coating electrosynthesis: Coatings were applied by ECP, in aqueous medium, of 
0.1 M HEMA and 0.1 M HEMA copolymerised with 0.05M MOEP (both from Fluka, 
Sigma­Aldrich, Milan, Italy) on Ti sheets measuring 1cm2. ECP process has already 
been described (De Giglio et al, 2009). Briefly, using cyclic voltammetry as electro­
chemical technique, with PAR 273 potentiostat­galvanostat (EG&G Princeton Applied 
Research, NY, USA), the potential was cycled between 0.0 V and ­1.2 V (vs Ag/AgCl, 
KCl sat.) for 20 cycles (scan rate 100 mV/s). 
X-ray Photoelectron Spectroscopy (XPS) analysis: XPS spectra were obtained with a 
ThermoVG Thetaprobe spectrometer (Thermo Fisher Scientific, Inc., Waltham, MA, 
USA) equipped with a microspot monochromatised AlKa source. The AlKa line 
(1486.6 eV) was used throughout; the base pressure was 10­9 mbar. Survey scans 
(binding energy range 0­1200 eV, FAT mode, pass energy = 150 eV) and detailed spec­
tra (FAT mode, pass energy = 50 eV) were recorded. Data were analysed using the 
Advantage software package, consisting of a non­linear least­squares fitting program. 
The experimental points of the detailed spectra were fitted using Gaussian­Lorentzian 
peaks according to fitting models previously applied (De Giglio et al, 2009).
rhVEGF entrapment and release: rhVEGF (ProSpec­Tany TechnoGene Ltd, Rehovot, 
Israel) was entrapped in the ECP p(HEMA­MOEP) films by dipping the coated Ti 
sheets into a PBS solution containing rhVEGF (50 µg/mL) for 2 h. The sheets were 
then rinsed with PBS and dried under a nitrogen flux. To assess rhVEGF entrapment, 
coatings were incubated with anti­VEGF monoclonal antibody (Santa Cruz Biotech­
nology Inc., CA, USA) for 1 h at room temperature. A FITC­conjugated rabbit­anti­
mouse IgG antibody (1:500, AlexaFluor®, Invitrogen, Milan, Italy) was added for 30 
min. Fluorescent immunocomplex VEGF was visualised with an inverted confocal 
microscope (CLSM510, Zeiss, USA). rhVEGF release was assessed after incubation 
(48 h) of specimens in DMEM or PBS using a commercial enzyme immunoassay kit 
(human VEGF ELISA kit, DBA, Milan, Italy). 
Antibiotic entrapment and release: Ciprofloxacin (CIP) was entrapped within hydro­
gel coatings after ECP by dipping titanium sheets in antibiotic solution 100 mg/mL 
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or 1000 mg/mL in NaCl 0.9%, for 2 h at 37°C. Finally the sheets were removed from 
the solution and rinsed with distilled water. CIP release from pHEMA hydrogel coat­
ings was monitored in a physiological solution (NaCl 0.9%) at 37°C. An amount of 
the solution was drawn after 48 h and used for HPLC assay standard curve. The cip­
rofloxacin detection was carried out using a high­performance liquid chromatograph 
(Agilent Technologies Ltd, Santa Clara, CA, USA) Model 1100 and an UV­DAD (Agi­
lent Technologies Ltd. mod. 1100) equipped with BIORAD software for signal analy­
sis. The chromatographic separation was allowed by a Restek RP­C18 analytical col­
umn (5 µm, 250 mm x 4.6 mm internal diameter) (Kamberi et al, 1998). 
Cell cultures: MG­63 human osteoblast­like cells (ATCC, Rockville, MD, USA) were 
cultured in 5% CO2 controlled atmosphere (T=37°C) in Dulbecco’s modified Eagle’s 
medium (DMEM; Sigma) supplemented with 10% foetal bovine serum (FBS), 1% 
L­glutamine (Sigma), and 1% antibiotics (penicillin­streptomycin; Gibco­Ivitrogen, 
Milan, Italy). After thawing they were routinely split 1:10 every 2­3 days and used at 
the 4th passage. MG63 cells were detached using 0.25% trypsin in 1mM EDTA (Sigma) 
and plated in triplicate onto the ECP coated Ti materials in 24­well polystyrene tis­
sue culture plates (TCPs) at a density of 1x104cells/cm2 and directly onto TCPs wells 
used as control. Cell behaviour was assessed at 48 h (on the basis of coating swelling 
time) and, on samples modified in order to improve mineralization, also at 21 days. 
Three different experiments where performed (n=9).
MTT (3-dimethylthiazol-2,5-diphenyltetrazolium bromide) colorimetric assay: After incu­
bation (48 h and 21 days) the medium was removed; 200 mL of MTT (Aldrich 135038, 
Sigma) solution (5 mg/mL in DMEM without phenol red) and 1.8 mL DMEM were 
added to all cell monolayers; the multi­well plates were incubated at 37°C for a fur­
ther 4 h. After discarding the supernatants, the dark blue formazan crystals were dis­
solved by adding 2 mL of solvent (4% HCl 1N in isopropanol absolute) and quanti­
fied by spectrophotometry (Secomam, Anthelie light, version 3.8, Contardi, Italy) at 
570 nm. The results are reported as percentage of TCPs cultures (controls). 
Scanning Electron Microscopy (SEM): Specimens were observed with a Philips XL 
20 scanning electron microscope using the secondary electron detector (FEI Italia SRL, 
Milan, Italy). For SEM analysis specimens were fixed in 2% glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.4), post­fixed in 1% osmium tetroxide, dehydrated in increas­
ing ethanol concentrations, critical point dried, mounted on aluminium stubs and 
gold­sputtered. 
Osteocalcin mRNA: After 21 days in culture total RNA was extracted (Trizol, Inv­
itrogen, Milan, Italy). Reverse­transcription and real­time PCR of quantified RNA 
amounts from samples and controls were performed using the Super Script III Plati­
num Two Step qRT­PCR Kit with SYBR Green (Invitrogen Invitrogen, Milan, Italy). 
Aliquots of cDNA were amplified with specific primers for GAPDH (internal control) 
and osteocalcin. The reaction was run in an MJ Research PTC­200 Chromo 4 (GMI 
Inc. Ramsey, Minnesota, USA). 
Results
Coating characterization: Electrosynthesis of pHEMA and p(HEMA­MOEP) on the 
Ti substrates yielded thin, adherent coatings that displayed some differences in their 
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voltammograms. XPS analysis of the pHEMA coatings demonstrated only carbon and 
oxygen signals in the wide­scan spectra, while when MOEP copolymers were ana­
lysed phosphorus was also detected. Negatively charged phosphate groups on the 
surface of p(HEMA­MOEP) were obtained by an alkaline treatment. XPS analysis 
performed on hydrogel thin coatings dipped in a CIP solution evidenced the pres­
ence of fluorine, which is a typical marker element for XPS investigation of CIP mol­
ecule (data not shown).
Entrapment and release of rhVEGF: Fine, diffuse rhVEGF positivity was demonstrat­
ed on the homogeneous surface network of p(HEMA­MOEP)­coated Ti surfaces (data 
not shown). Different amounts of rhVEGF were detected by ELISA after 48 h incu­
bation of rhVEGF­containing p(HEMA­MOEP) in PBS (660+40 pg/mL) or DMEM 
(920+55 pg/mL), respectively.
CIP release detection: HPLC has been employed to quantify CIP release from the 
electrosynthesised coatings. CIP amounts, released after 48 h of incubation, were of 
0.280+0.003 µg/mL for pHEMA loaded with 100 µg/mL of CIP and of 0.660+0.002 µg/mL 
when the loaded amount was of 1000 µg/mL of CIP
Cell behaviour: The MTT test documented good MG­63 cell viability at 48 h and 21 
days (Figure 1). No significant differences in cell adhesion, morphology and viability 
were detected when 100 mg/mL or 1000 mg/mL of antibiotic were tested. At 48 h 
SEM examination of cells seeded onto the electrosynthesised coatings showed evident 
cell spreading, indicating good attachment to the substrate. Moreover, SEM images 
of MG63 underline that the presence and/or release of antibiotic do not affect cell 
behaviour (fig. 2). At 21 days most MG63 cells grown on pHEMA (fig. 3a) displayed 
an elongated morphology, whereas on p(HEMA­MOEP) they appeared more spread 
(fig. 3b), as activated osteoblasts. Ostecalcin mRNA expression 21 days into culture 
was not significantly different between the coatings (0.82 pHEMA and 0.63 pHEMA­
MOEP, respectively) and was comparable to that of MG63 cells cultured on TCPs 
without osteogenic conditioning media (not shown). 
Discussion
Titanium, pure or alloyed with other elements, is a widely used material for bio­
medical applications, due to its corrosion resistance, excellent biocompatibility, high 
mechanical performance, and good workability. For the application in dental and 
orthopaedic fields, a key parameter to achieve implant osseointegration, in addition 
to the biomechanical factors related to its geometry and shape, is the kind of interac­
tion between the implant and the surrounding biological tissues. Indeed, a key role 
is played by the topography and chemistry of the implant surface (Tache et al, 2004). 
In this work, the biocompatibility of differently modified of p(HEMA) polymer­
ic coatings electrosynthesized on titanium substrates has been experimented using 
MG63 human osteoblast­like cells as representative cell culture model (Rausch­Fanm 
et al, 2008). 
The ECP of thin p(HEMA­MOEP) coatings was devoted to promote both minerali­
zation, due to the presence of negatively charged functional groups on the polymer­
ic surface, and angiogenesis by release of entrapped rhVEGF as a result of hydrogel 
swelling properties. Our data were consistent with a good compatibility p(HEMA­
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MOEP) electrosynthesized coatings. At 21 days of culture, even though features of 
cell activation were detected, no significant differences in mRNA ostecalcin expres­
sion were evidenced between negatively charged p(HEMA­MOEP) and pHEMA coat­
ings. This aspect was in contrast with the results on the in vitro calcification processes 
by means of Simulated Body Fluid (SBF) in which an improvement in mineralization 
related to the presence of suitable functional groups was found (data not shown). 
Therefore it could be argued that for in vivo mineral deposition the requirement of a 
specific microenvironment other than cell system is a major need. 
The loading of our coatings with antibiotic (CIP) was devoted to its release direct­
ly in the site of the implant, since implant­associated infections represent an occa­
sional but serious problem in surgery. On CIP­loaded pHEMA coatings, cell behavior 
does not seem to be affected by the different CIP concentrations, as no significant dif­
ferences in cell adhesion, morphology and viability were detected. 
In conclusion, in this work the biocompatibility of new bioactive titanium 
implants coatings obtained by ECP of polyacrylic hydrogel films have been assessed. 
The obtained results suggest that these modified hydrogel coatings could represent 
an effective approach to favour bone­implant integration or to prevent bacterial infec­
tions without affecting osteoblast functions pertinent to new bone formation.
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Figures
Figure 1 – MTT viability test of MG63 cultured on the different modified pHEMA coatings for 48h and 21 
days. Data are expressed as percentage over control cultures (TCPs)
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Figure 2 – SEM micrographs of MG63 
cells cultured for 48h on pHEMA (a), 
p(HEMA–MOEP) (b) and CIP-loaded 
pHEMA (c) displaying a star-shaped 
morphology and adhesion to the sub-
strate by means of filopodia. Figure 
scale bar 20µm.
Figure 3 – SEM micrographs of MG63 cells cultured for 21d on 
pHEMA (a) and p(HEMA–MOEP): note the marked spreading of 
cells cultured on and p(HEMA–MOEP). Figure scale bar 10µm
